Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa for Ischemic Protection in Aortic Surgery
NCT00647998Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 2008
- Primary completion
- Jul 2010
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 2, open-label trial of darbepoetin alfa in spinal cord ischemia and stroke (2 arms), sponsored by University of Pennsylvania. Primary endpoint: Death or Neurologic Disability. Started Jan 2008; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
spinal cord ischemiastroke
Beyond the preview
Go deeper on NCT00647998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647998.